Blood pressure reduction due to hemoglobin glycosylation in type 2 diabetic patients

Pedro Cabrales1, Miguel A Salazar Vázquez2,3, Beatriz Y Salazar Vázquez3,4, Martha Rodríguez-Morán5, Marcos Intaglietta4, Fernando Guerrero-Romero51La Jolla Bioengineering Institute, La Jolla, California, USA; 2Hospital Regional No. 1, of the Mexican Social Security Institute, Victoria de Durango, Dgo. Mexico; 3Faculty of Medicine and Dept. of Physical Chemistry, Universidad Juárez del Estado de Durango, Victoria de Durango, Dgo. Mexico; 4Department of Bioengineering, University of California, San Diego, La Jolla, California, USA; 5Biomedical Research Unit, of the Mexican Social Security Institute, Victoria de Durango, Dgo. MexicoObjective: To test the hypothesis that glycosylation of hemoglobin constitutes a risk factor for hypertension.Methods: A total of 129 relative uniform diabetic subjects (86 women and 42 men) were enrolled in a cross-sectional study. Exclusion criteria included alcohol consumption, smoking, ischemic heart disease, stroke, neoplasia, renal, hepatic, and chronic inflammatory disease. Systolic and diastolic pressures were recorded in subsequent days and mean arterial blood pressure (MAP) was determined. Hemoglobin glycosylation was measured by determining the percentage glycosylated hemoglobin (HbA1c) by means of the automated microparticle enzyme immunoassay test.Results: MAP was found to be independent of the concentration of HbA1c; however, correcting MAP for the variability in hematocrit, to evidence the level of vasoconstriction (or vasodilatation) showed that MAP is negatively correlated with the concentration of HbA1c (p for trend <0.05), when patients treated for hypertension are excluded from the analysis. Patients treated for hypertension showed the opposite trend with increasing MAP as HbA1c increased (p for the difference in trends <0.05).Conclusions: Glycosylation per se appears to lead to blood pressure reduction in type 2 diabetic patients untreated for hypertension. Treatment for hypertension may be associated with a level of endothelial dysfunction that interferes with the antihypertensive effect of HbA1c.Keywords: diabetes, hemoglobin glycosylation, hypertension, hematocrit, nitric oxid

Reducing deforestation and improving livestock productivity: greenhouse gas mitigation potential of silvopastoral systems in Caquetá

Colombia's agriculture, forestry and other land use sector accounts for nearly half of its total greenhouse gas (GHG) emissions. The importance of smallholder deforestation is comparatively high in relation to its regional counterparts, and livestock agriculture represents the largest driver of primary forest depletion. Silvopastoral systems (SPSs) are presented as agroecological solutions that synergistically enhance livestock productivity, improve local farmers' livelihoods and hold the potential to reduce pressure on forest conversion. The department of Caquetá represents Colombia's most important deforestation hotspot. Targeting smallholder livestock farms through survey data, in this work we investigate the GHG mitigation potential of implementing SPSs for smallholder farms in this region. Specifically, we assess whether the carbon sequestration taking place in the soil and biomass of SPSs is sufficient to offset the per-hectare increase in livestock GHG emissions resulting from higher stocking rates. To address these questions we use data on livestock population characteristics and historic land cover changes reported from a survey covering 158 farms and model the carbon sequestration occurring in three different scenarios of progressively-increased SPS complexity using the CO2 fix model. We find that, even with moderate tree planting densities, the implementation of SPSs can reduce GHG emissions by 2.6 Mg CO2e ha−1 yr−1 in relation to current practices, while increasing agriculture productivity and contributing to the restoration of severely degraded landscapes

Interleukin 18 maintains a long-standing inflammation in coeliac disease patients

Producción CientíficaDietary gluten induces an early response in the intestine of coeliac disease patients (CD), within a few hours, and this is driven by high levels of proinflammatory cytokines, including IFNg and IL-15, as has been thoroughly shown by gluten stimulation of biopsy explants. Our aim was to identify the immune mediators involved in the long-standing inflammation in untreated CD patients at diagnosis. mRNA and protein levels of TNFa, IL-12(p35), IL-12(p40), IL-15, IL-18 and IL-23(p19) were quantified in biopsies from active CD patients, CD patients on a gluten-free diet (GFD), healthy controls, and patients with non-CD inflammation and mild histological changes in the intestine. Biopsies from CD patients on a GFD were also stimulated in vitro with gliadin, and protein expression of IL-15 and IL-18 was analysed. Levels of IL-12 and IL-23 mRNA are nearly absent, and TNFa levels remain unchanged among different groups. Both the active and inactive forms of IL-18 protein have been found in all samples from active CD, and protein expression was only localized within the crypts. Levels of IL-15 mRNA remain unchanged, and protein expression, localized within the lamina propria, is found in a small number of samples. In vitro stimulation with gluten induces the expression of IL-15 and IL-18. In active CD, the early response following gluten intake characterized by high IFNg levels is driven by IL-18, and probably IL-15, and this alternates with periods of long-standing inflammation with moderate IFNg levels, maintained by IL-18 alone

VO2peak and Watt exercise testing: arm crank vs cycle ergometry

INTRODUCTION: Multiple sclerosis is a disease of the central nervous system that primarily affects the strength and functional capacity of the lower extremities. PURPOSE: The objectives of the present study were evaluate VO2peak and the power output (W) during a leg and an arm test performance in relapsing-remitting multiple sclerosis (MS) versus healthy people (HP). METHODS: Twelve women (age 45.8 ± 11.8 yr) with MS (EDSS 3.3 ± 1.8) and twelve women (age 45.6 ± 10.7 yr) HP were included in this study. They underwent two incremental exercise tests on an electromechanical braked arm crank ergometer and on an electromagnetic braked leg cycling ergometer separately. A computerized gas analysis system collected and analyzed gas exchange during the two kinds of testing. The statistical analysis was determined with the Wilcoxon test. RESULTS: First, VO2peak (21.5 ± 5.9 vs. 30.5 ± 4.8 ml·kg·min-1, p = 0.001) y W (84.5 ± 30.1 vs. 141.0 ± 13.7, Watt, p =0.0001) during cycle ergometer test were significantly lower in MS compared with HP. Similarly, the VO2peak in MS during arm crank was significantly lower (16.7 ± 5.4 vs. 23.4 ± 5.1 ml·kg·min-1, p = 0.023) compared with HP. However, the power generated by the arm was not different between the groups. CONCLUSION: The patients with MS during leg ergometer test showed a lower VO2peak. In the same sense, the patients with MS showed lower VO2peak in the test performed with the arms. Interestingly, the power generated with arms was similar in the two groups. These results indicate, that the patients with MS reflect a greater affectation to produce high loads of physical work with legs but not with arms. Further research is suggested where both the lower and upper extremities are involved to improve the processes of rehabilitation in MS

Extraction of 2′-O-apiosyl-6′-O-crotonic acid-betanin from the ayrampo seed (Opuntia soehrensii) cuticle and its use as an emitting layer in an organic light-emitting diode

The molecule 2′-O-apiosyl-6′-O-crotonic acid-betanin (called Achkiy) was obtained after an ecofriendly and low-cost purification process of the extract from the ayrampo seed cuticle. Results from EDS give us an idea of the organic elements present in the ayrampo cuticle layer composed of carbon, oxygen and nitrogen. Further characterization analysis of ayrampo extract by Fourier Transform Infrared Spectrophotometry (FTIR) corroborated the presence of characteristic functional groups corresponding to carboxyl, carbonyls, hydroxyls and secondary amines. On the other hand, we have confirmed by absortion peak the glucose, apiosyl, crotonic acid and betanin at 227 nm, 276 nm, 291 nm and 534 nm bands respectively. Mass Spectrometry (MS) characterization was used finally to identify the electroactive Achkiy molecule. This molecule was tested in an Organic Light Emitting Diode (OLED) achieving a luminance of 4.8 Cd m$^{−2}$ when bias voltage of 16.5 V and a current of 34.1 mA was applied. In addition, the irradiance generated by the Achkiy layer reaches a value of ≈ 113.3 μW m$^{−2}$ emitting light with a λ ≈ 390.10 nm. These preliminary results report an interesting molecule extracted from a natural pigment wich emits light in the blue region